Approaches to treatment of patients with uric acid dysmetabolism


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Approaches to medical treatment of uric acid dymetabolism are discussed. Clinical case, illustrating the efficacy of most widely used therapeutical schemes are presented. Indications for use of drugs, inducing the salvation of uric acid in the urine are named; methods of prevention of uric acid crystallization in urinary tract are reviwed.

Full Text

Restricted Access

About the authors

A. V Scherbak

Email: ANNARD@YANDEX.ru

M. V Lebedeva

References

  1. Мухин Н.А., Фомин В.В., Лебедева М.В. Гиперурикемия как компонент кардиоренального синдрома // Терапевтический архив. - 2011. - № 6. - С. 5-12.
  2. Hunsicker L.G., Adler S., Caggiula A. et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study // Kidney Int. - 1997. - Vol. 51. - P. 1908.
  3. Лебедева М.В., Балкаров И.М., Мухин Н.А. Ранняя диагностика уратного поражения почек // Терапевтический архив. - 1997. - № 6. - С. 56-59.
  4. Suresh E., Das P. Recent advances in management of gout // QJM. - 2012. - Vol. 105(5). - P. 407-17.
  5. Yamanaka H. Japanese Society of Gout and Nucleic Acid Metabolism. Japanese guideline for the management of hyperuricemia and gout: second edition // Nucleotides Nucleic Acids. - 2011. - Vol. 30. - P. 1018.
  6. Мухин Н.А., Балкаров И.М., Моисеев С.В. и др. Урикозурическое действие лозартана // Клиническая фармакология и терапия. - 2003. - № 5. - С 55-58.
  7. Burns C. M., Wortmann R.L. Latest evidence on gout management: what the clinician needs to know // Ther Adv Chronic Dis. - 2012. - Vol. 3(6). - P. 271-286.
  8. Балкаров И.М., Щербак А.В., Лебедева М.В. и др. Уратная нефропатия в семьях больных подагрой // Клиническая геронтология. - 2005. - № 11(4). - С. 42-46.
  9. Anzai N., Enomoto A., Renal urate handling: clinical relevance of recent advances // PloS Genet. - 2009. - Vol. 5(6). - P. e1000504.
  10. Xu H., Zisman A.L., Coe F.L. et al. Kidney stones: an update on current pharmacological management and future directions // Expert Opin Pharmacother. - 2013. - Vol. 14(4). - P. 435-447.
  11. Trinchieri A., Esposito N., Castelnuovo C. Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate/potassium bicarbonate // Arch. Ital. Urol. Androl - 2009. - Vol. 81. - P. 188.
  12. Gaffo A.L., Saag K.G. Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout // Core Evid. - 2010. - Vol. 15;4. - P. 25-36.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies